CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong
· Delayed Price · Currency is HKD 6.14
-0.01 (-0.16%)
Apr 24, 2025, 4:08 PM HKT
CSPC Pharmaceutical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 5,873 | 6,091 | 5,605 | 5,160 | Upgrade
|
| Depreciation & Amortization | - | 1,083 | 1,004 | 862.38 | 804.45 | Upgrade
|
| Other Amortization | - | 34.94 | 43.45 | 3.1 | 4.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 22.23 | 7.36 | 10.79 | -285.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 42.32 | 72.11 | 50 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 177.85 | -148.97 | -242.41 | -568.29 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 54.2 | 15.4 | -22.44 | -13.53 | Upgrade
|
| Stock-Based Compensation | - | 235.09 | 160.73 | 17.73 | 9.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 18.41 | -25.73 | 4.07 | 9.69 | Upgrade
|
| Other Operating Activities | - | -330.26 | -391.27 | -263.85 | -60.75 | Upgrade
|
| Change in Accounts Receivable | - | -1,973 | -566.55 | -943.55 | -445.45 | Upgrade
|
| Change in Inventory | - | -583.75 | -42.75 | -617.07 | 601.44 | Upgrade
|
| Change in Accounts Payable | - | 918.13 | 18.45 | 276.79 | 337.71 | Upgrade
|
| Change in Unearned Revenue | - | -275.07 | 468.63 | -44.22 | 291.57 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,118 | 920.34 | -59.87 | 894.92 | Upgrade
|
| Operating Cash Flow | - | 4,179 | 7,627 | 4,637 | 6,740 | Upgrade
|
| Operating Cash Flow Growth | - | -45.21% | 64.50% | -31.20% | 78.11% | Upgrade
|
| Capital Expenditures | - | -1,624 | -2,220 | -1,410 | -1,356 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 139.99 | 16.83 | 85.69 | 28.83 | Upgrade
|
| Cash Acquisitions | - | - | -341.91 | -24.35 | -18.13 | Upgrade
|
| Divestitures | - | - | - | 150.91 | -302.42 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -265.43 | -484.54 | -339.15 | -21.49 | Upgrade
|
| Investment in Securities | - | 2,171 | -4,075 | 630.71 | -450.06 | Upgrade
|
| Other Investing Activities | - | 184.9 | 308.74 | 269.01 | -10.01 | Upgrade
|
| Investing Cash Flow | - | 607.27 | -6,796 | -637.33 | -2,130 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 169 | Upgrade
|
| Long-Term Debt Issued | - | - | 485.71 | - | - | Upgrade
|
| Total Debt Issued | - | - | 485.71 | - | 169 | Upgrade
|
| Long-Term Debt Repaid | - | -166.43 | -620.95 | -222.17 | -92.32 | Upgrade
|
| Total Debt Repaid | - | -166.43 | -620.95 | -222.17 | -92.32 | Upgrade
|
| Net Debt Issued (Repaid) | - | -166.43 | -135.24 | -222.17 | 76.68 | Upgrade
|
| Repurchase of Common Stock | - | -200.36 | -14.21 | -263.51 | - | Upgrade
|
| Common Dividends Paid | - | -2,726 | -2,097 | -1,691 | -1,528 | Upgrade
|
| Other Financing Activities | - | 792.06 | 342.34 | -20.16 | -19.96 | Upgrade
|
| Financing Cash Flow | - | -2,301 | -1,904 | -2,197 | -1,471 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 4.89 | 14.14 | -2.44 | 2.1 | Upgrade
|
| Net Cash Flow | - | 2,490 | -1,059 | 1,800 | 3,141 | Upgrade
|
| Free Cash Flow | - | 2,555 | 5,407 | 3,226 | 5,383 | Upgrade
|
| Free Cash Flow Growth | - | -52.74% | 67.58% | -40.07% | 183.19% | Upgrade
|
| Free Cash Flow Margin | - | 8.12% | 17.48% | 11.58% | 21.58% | Upgrade
|
| Free Cash Flow Per Share | - | 0.21 | 0.45 | 0.27 | 0.45 | Upgrade
|
| Cash Interest Paid | - | 15.99 | 21.54 | 7.66 | 12.23 | Upgrade
|
| Cash Income Tax Paid | - | 1,309 | 1,335 | 1,141 | 1,061 | Upgrade
|
| Levered Free Cash Flow | - | 1,164 | 3,826 | 1,721 | 4,120 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,180 | 3,841 | 1,726 | 4,128 | Upgrade
|
| Change in Net Working Capital | 1,224 | 2,669 | -1,113 | 1,314 | -1,268 | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.